Table 2.
CD (n = 123) | SC (n = 84) | P value SC vs CD | Healthy volunteers (n = 114) | P value HL vs CD | |
---|---|---|---|---|---|
Age, median (IQR) | 32.4 (24.9–50.7) | 32.8 (26.4–45.5) | .9a | 32.3 26.4–40.6) |
.4a |
Females, n (%) | 58 (47.9) | 39 (52.7) | .6b | 59 (50.4) | .8b |
Smoking status | |||||
Current | 53 | 17 | Current vs ex/never | 24 | Current vs ex/never |
Ex | 29 | 17 | .005 | 32 | .0005 |
Never | 39 | 40 | Ever vs never | 56 | Ever vs never |
Unknown | 0 | 0 | .004 | 5 | .008 |
CRP | 8 (2–23) | 0 (0–3.5) | .006a | ||
ESR | 18 (5–39) | 6 (4.5–7.5) | .002a | ||
FC | 495 (135–828) | 19 (19–37) | .0001a |
CD, Crohn’s disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; FC, fecal calprotectin; HL, healthy laboratory volunteers; IQR, interquartile range; SC, symptomatic control subjects; UC, ulcerative colitis.
Adapted with permission from Ventham et al.
Wilcoxon rank sum test.
Chi-square test.